HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Armel Stockis Selected Research

brivaracetam

2/2022Bioavailability, safety and tolerability of intravenous brivaracetam in healthy Japanese participants.
1/2020A review of the drug-drug interactions of the antiepileptic drug brivaracetam.
12/2019Pharmacokinetic interaction of brivaracetam on other antiepileptic drugs in adults with focal seizures: Pooled analysis of data from randomized clinical trials.
8/2019Safety and Tolerability of Adjunctive Brivaracetam in Pediatric Patients < 16 Years with Epilepsy: An Open-Label Trial.
6/2018Off-line solid phase extraction and liquid chromatography-tandem mass spectrometry method for the quantitation of brivaracetam acid metabolites: Method validation and application to in vitro metabolism assays.
1/2018Brivaracetam-induced elevation of carbamazepine epoxide levels: A post-hoc analysis from the clinical development program.
1/2018Extrapolation of a Brivaracetam Exposure-Response Model from Adults to Children with Focal Seizures.
1/2018Human abuse potential of brivaracetam in healthy recreational central nervous system depressant users.
11/2017Evaluation of brivaracetam efficacy as monotherapy in adult patients with focal seizures.
6/2017Brivaracetam population pharmacokinetics in children with epilepsy aged 1 month to 16 years.
For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Armel Stockis Research Topics

Disease

24Epilepsy (Aura)
02/2022 - 01/2007
19Seizures (Absence Seizure)
01/2020 - 12/2003
5Body Weight (Weight, Body)
01/2019 - 03/2007
4Sleepiness
08/2019 - 05/2006
2Dizziness (Lightheadedness)
01/2018 - 05/2006
1Ataxia (Dyssynergia)
01/2018
1Poisoning
01/2018
1Diplopia (Double Vision)
01/2018
1Partial Epilepsies (Epilepsy, Partial)
11/2014
1Chronic Kidney Failure (Chronic Renal Failure)
11/2014
1Lethargy
09/2010
1Headache (Headaches)
09/2010
1Tachycardia (Tachyarrhythmias)
09/2010
1Contusions
09/2010
1Idiopathic Generalized Epilepsy
07/2009
1Asthma (Bronchial Asthma)
01/2005
1Hypersensitivity (Allergy)
01/2005

Drug/Important Bio-Agent (IBA)

20brivaracetamIBA
02/2022 - 06/2007
14Levetiracetam (Keppra)FDA LinkGeneric
08/2015 - 12/2003
10LigandsIBA
06/2018 - 07/2008
9Anticonvulsants (Antiepileptic Drugs)IBA
01/2020 - 12/2003
9Proteins (Proteins, Gene)FDA Link
06/2018 - 07/2008
5Carbamazepine (Tegretol)FDA LinkGeneric
01/2018 - 04/2007
4Pharmaceutical PreparationsIBA
08/2019 - 03/2007
4LacosamideFDA Link
01/2019 - 11/2014
3Valproic Acid (Depakote)FDA LinkGeneric
12/2016 - 04/2007
2carbamazepine epoxideIBA
12/2019 - 01/2018
1SolutionsIBA
08/2019
1Blood Proteins (Serum Proteins)IBA
11/2014
1CreatinineIBA
11/2014
1Amino AcidsFDA Link
11/2014
1Topiramate (Topamax)FDA LinkGeneric
11/2007
1Lamotrigine (Lamictal)FDA LinkGeneric
11/2007
1Cetirizine (Zyrtec)FDA LinkGeneric
01/2005
1levocetirizineFDA LinkGeneric
01/2005

Therapy/Procedure

5Therapeutics
11/2017 - 04/2007
2Intravenous Administration
02/2022 - 11/2013
1Oral Administration
11/2013
1Intravenous Infusions
03/2007